Highlights a 1.2% prevalence of Candida bloodstream infections in ECMO patients while emphasizing the need to account for the heterogeneity between veno-venous and veno-arterial ECMO populations.
fections in patients under extra-corporeal membrane oxygenation (ECMO) of the Extracorporeal Life Support Organization registry They found a 1.2% prevalence of Candida bloodstream infections (BSI). However, we highlighted the heterogeneity of this mixed population treated with veno-venous (VV) and veno-arterial (VA) ECMO and the scarce available data, in particular the delay from ECMO to infection
No takes yet. Share an insight, caveat, or question.
Roux et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: